- US-listed companies
- INSMED Inc
- Cash flow
INSMED Inc (INSM) Cash flow
Market cap
$29.1B
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Depreciation & amortization | 0 | 1 | 1 | 1 | 2 | 2 | 3 | - | - | - | - | - | - | - | - |
| Stock-based compensation | 2 | 3 | 9 | 11 | 16 | 18 | 18 | 26 | 27 | 36 | 46 | 58 | 75 | 97 | 153 |
| Cash from operations | -30 | -31 | -47 | -64 | -101 | -147 | -160 | -258 | -251 | -219 | -363 | -400 | -536 | -684 | -935 |
| Capital expenditures | -1 | -0 | -1 | -5 | -3 | -4 | -3 | -13 | -42 | -6 | -7 | -10 | -13 | -22 | -33 |
| Cash from investing | 34 | 62 | 1 | -5 | -3 | -4 | -3 | -15 | -42 | -7 | -64 | -35 | -224 | -583 | -65 |
| Proceeds from issuance of term debt, net | - | 20 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from financing | -0 | 45 | 68 | 115 | 228 | 31 | 381 | 387 | 285 | 271 | 613 | 793 | 168 | 1,341 | 954 |
| Free cash flow | |||||||||||||||
| FCF margin (%) | - | - | - | - | - |